Literature DB >> 3099273

Objective relief of vasospasm by glyceryl trinitrate in secondary Raynaud's phenomenon.

J S Coppock, J M Hardman, P A Bacon, K L Woods, M J Kendall.   

Abstract

An objective response to topical glyceryl trinitrate was shown by digital plethysmography in a study of 17 patients with Raynaud's phenomenon. Improvement was significant (P less than 0.005) in those in whom the disease was secondary to an underlying connective tissue disorder. The response suggests that the effect of this drug is mediated locally.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3099273      PMCID: PMC2418552          DOI: 10.1136/pgmj.62.723.15

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  12 in total

1.  Percutaneous nitroglycerin absorption in rats.

Authors:  S T Horhota; H L Fung
Journal:  J Pharm Sci       Date:  1979-05       Impact factor: 3.534

2.  Difference in nitroglycerin dose-response in the venous and arterial beds.

Authors:  P R Imhof; B Ott; P Frankhauser; L C Chu; J Hodler
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

3.  Prevalence of primary Raynaud phenomena in young females.

Authors:  N Olsen; S L Nielsen
Journal:  Scand J Clin Lab Invest       Date:  1978-12       Impact factor: 1.713

4.  Raynaud phenomena and finger systolic pressure during cooling.

Authors:  S L Nielsen
Journal:  Scand J Clin Lab Invest       Date:  1978-12       Impact factor: 1.713

5.  The clinical significance of Raynaud's syndrome.

Authors:  J M Porter; E J Bardana; G M Baur; D H Wesche; R H Andrasch; J Rösch
Journal:  Surgery       Date:  1976-12       Impact factor: 3.982

6.  Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease.

Authors:  A G Franks
Journal:  Lancet       Date:  1982-01-09       Impact factor: 79.321

7.  Measurement of digital blood pressure after local cooling.

Authors:  S L Nielsen; N A Lassen
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-11

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

9.  A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.

Authors:  A Kahan; B Amor; C J Menkes
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

10.  Analysis of coronary responses to various doses of intracoronary nitroglycerin.

Authors:  R L Feldman; J D Marx; C J Pepine; C R Conti
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

View more
  5 in total

Review 1.  Is there counter-current exchange of drugs in limbs after percutaneous absorption?

Authors:  J F Hecker
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

2.  A controlled trial of the effect of topical glyceryl trinitrate on skin blood flow and skin elasticity in scleroderma.

Authors:  A L Herrick; R J Gush; M Tully; M I Jayson
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

3.  Use of nitroglycerin ointment to treat primary and secondary Raynaud's phenomenon: a systematic literature review.

Authors:  Olivia Qiu; Theresa Chan; Matthew Luen; Joseph E Cruz; Evelyn R Hermes-DeSantis
Journal:  Rheumatol Int       Date:  2018-08-22       Impact factor: 2.631

Review 4.  Management of Raynaud's phenomenon. Focus on newer treatments.

Authors:  S Roath
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 5.  Advances in the treatment of Raynaud's phenomenon.

Authors:  Terri L Levien
Journal:  Vasc Health Risk Manag       Date:  2010-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.